RIYADH: The Saudi Food and Drug Authority has fined 24 pharmaceutical enterprises SR678,400 ($180,000) for failing to deliver authorised items in the local market.
According to the Saudi Press Agency, the SFDA highlighted violations such as failing to submit to the authority’s drug track and trace system, failing to warn the authority of potential shortages or supply interruptions, and failing to maintain enough product supplies.
The SFDA said it penalised the 24 enterprises by its product rules for pharmaceutical, herbal, and health product makers.
According to the rules, pharmaceutical and herbal makers, as well as warehouses, must keep enough stockpiles of all registered items for six months, based on annual data examined by the SFDA. Any supply shortages must be resolved within three months, unless the authority decides to terminate the product registrations.
This coincides with the SFDA’s objective to ensuring that pharmaceutical facilities follow its laws, assuring the availability of medicine throughout the Kingdom. Penalties of up to SR5 million may be imposed, in addition to the facility’s potential closure or licence cancellation.
Also Read:
Advancing HSE Management with ASSP – Kuwait Chapter: Bader Al-Hadhrami
Empowering Businesses With Ultimate Payment Solutions With Pine Labs: Dounia Jouron
